Developing and manufacturing peptide-based therapies can be both scientifically and financially challenging. We invite you to join our upcoming webinar for a scientific deep dive on Cambrex's liquid-phase peptide synthesis technology, which significantly reduces solvent demand and the need for excess reagents compared to standard solid-state peptide synthesis processes. Register here: https://lnkd.in/ewxcAxHf
Peptide-based therapeutics are thriving, prompting advances in their manufacturing. This webinar features Cambrex experts discussing liquid-phase peptide synthesis (LPPS), peptide crystallization, and impurity analysis methods. Key topics include LPPS vs. solid-phase synthesis, scalable production workflows, advantages of crystallization, and analytical techniques like HPLC and LC-MS for purity and sequencing. #Cambrex #LPPS #Peptide
This content isn’t available here
Access this content and more in the LinkedIn app